Arca
Skip to content

Extracorporeal Shock Wave Lithotripter (U200)

Lithotriptor, Extracorporeal Shock-Wave, Urological. 510(k) K242922, from Shenzhen Wikkon Precision Technologies Co., Ltd. (Shenzhen, CN). Product code LNS, class 2.

As of Nov 16, 2026, K242922 is an FDA 510(k) held by Shenzhen Wikkon Precision Technologies Co., Ltd., substantially equivalent on Jun 18, 2025 after 267 days, with no recalls tied to it in FDA's recall database.

  • Substantially equivalent: Jun 18, 2025
  • Review time: 267 days
  • Recalls: 0

Indications for Use

As the 510(k) summary states them, read from FDA's summary PDF

The Extracorporeal Shock Wave Lithotripter, model: U200, is intended to fragment urinary stones in the kidney (renal pelvis and renal calyces) and ureter (upper, middle, and lower ureter).

Predicate Devices

The legally marketed devices this 510(k) summary says it is substantially equivalent to, read from FDA's summary PDF

Other LNS Clearances

The newest 510(k)s for the same product code; their median review was 237 days; see every LNS device

Record

Type
Traditional
Received
Sep 24, 2024
Review panel
Gastroenterology, Urology
Regulation
21 CFR 876.5990

One page per 510(k), De Novo and original PMA. Recalls are those FDA's recall database ties to this number; recalls of related devices that cite another number are not shown. Refreshed weekly. Predicates are read by Arca from the text of FDA's 510(k) summary PDFs, most of them scans: a device number counts when the summary names it as a predicate or as the device it is substantially equivalent to. About 97% of those read were right on a sample we checked by hand; summaries from before 2000 often name predicates without a number, so older devices show fewer. Pivotal studies are read by a model from FDA's De Novo decision summaries and PMA SSEDs; a count or result is shown only when its numbers appear in FDA's text. openFDA device 510(k), PMA and recall files

Logos are each company's own site icon, matched by name through Wikidata.Company names and logos identify the companies in public FDA and registry records and do not imply endorsement.